Akanda Corp. (AKAN) Stock Price & Growth Analysis

Quote Panel

Updated October 12, 2024

1W -2.80 % 1M -12.61 % 3M -54.19 % 1Y -95.35 %

Key Metrics

Market Cap
1.99M
Shares Outstanding
1.92M
Share in Float
1.89M
Dividende
0

Earning Date
No Data
Price Target
1.04
Average Volume
530290
Beta
1.479

Range
0.9634-28.4
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.akandacorp.com
Sector
Healthcare

Fundamentals

Infinityx

P/E Ratio

0.96x

P/S Ratio

-0.04x

P/B Ratio

-1.0

Debt/Equity

-1494.2%

Net Margin

$-286.4

EPS

How AKAN compares to sector?

P/E Ratio

Relative Strength

AKAN

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q1.22

N/A

NA
vs NA

Q2.22

N/A

NA
vs NA

Q3.22

N/A

NA
vs -1.67

Q4.22

N/A

NA
vs -0.97

Q1.23

N/A

NA
vs NA

Q2.23

N/A

NA
vs NA

Q3.23

N/A

NA
vs NA

Q4.23

N/A

NA
vs NA

Q1.24

N/A

1.57
vs NA

Q2.24

N/A

1.34
vs NA

Sales Growth

YoY

Current

Estimates

Q1.22

+1757%

36.5K vs 2K

Q2.22

+3616%

73.1K vs 2K

Q3.22

+9385%

1.3M vs 13.4K

Q4.22

+10479%

2.5M vs 24.1K

Q1.23

+1812%

698.7K vs 36.5K

Q2.23

+1812%

1.4M vs 73.1K

Q3.23

-70%

381.3K vs 1.3M

Q4.23

-85%

381.3K vs 2.5M

Q1.24

-40%

418.9K vs 698.7K

Q2.24

-67%

460.1K vs 1.4M

Return on Equity

QoQ

Q1.22

+2%

0.02
vs 1.28

Q2.22

-7%

-0.07
vs 0.02

Q4.22

-17%

-0.17
vs -0.07

Q4.22

-34%

-0.34
vs -0.17

Q1.23

-14%

-0.14
vs -0.34

Q2.23

-27%

-0.27
vs -0.14

Q3.23

+345%

3.45
vs -0.27

Q4.23

+345%

3.45
vs 3.45

Institutionnal Ownership

QoQ

Q3.14

1
vs NA

Q1.22

6
vs NA

Q2.22

8
vs 6

33%

Q3.22

5
vs 8

-37%

Q4.22

7
vs 5

40%

Company Description

Infinityx

0.96x

-0.04x

-1.0

-1494.2%

$-286.4

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!